136 related articles for article (PubMed ID: 24967406)
1. Serum parathyroid hormone is a new potential risk factor in multiple myeloma.
Kang MG; Won EJ; Choi HW; Kim HR; Choi HJ; Park HR; Shin JH; Suh SP; Ryang DW; Shin MG
Biomed Res Int; 2014; 2014():804182. PubMed ID: 24967406
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
3. Serum Lactate Dehydrogenase Can Be Used as a Factor for Re-Evaluating First-Relapsed Multiple Myeloma.
Liu Y; Wen L; Chen H; Chen Y; Duan W; Kang Y; Ma L; Huang X; Lu J
Acta Haematol; 2020; 143(6):559-566. PubMed ID: 32610311
[TBL] [Abstract][Full Text] [Related]
4. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia.
Avram MM; Sreedhara R; Avram DK; Muchnick RA; Fein P
Am J Kidney Dis; 1996 Dec; 28(6):924-30. PubMed ID: 8957048
[TBL] [Abstract][Full Text] [Related]
5. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
6. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
[TBL] [Abstract][Full Text] [Related]
7. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
8. Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients.
Suriu C; Akria L; Azoulay D; Shaoul E; Barhoum M; Braester A
Int J Lab Hematol; 2016 Jun; 38(3):e56-9. PubMed ID: 27018225
[No Abstract] [Full Text] [Related]
9. Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.
Jean G; Souberbielle JC; Zaoui E; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Mehdi M; Chazot C
BMC Nephrol; 2016 Oct; 17(1):153. PubMed ID: 27756251
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
[TBL] [Abstract][Full Text] [Related]
11. High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
van Rhee F; Bolejack V; Hollmig K; Pineda-Roman M; Anaissie E; Epstein J; Shaughnessy JD; Zangari M; Tricot G; Mohiuddin A; Alsayed Y; Woods G; Crowley J; Barlogie B
Blood; 2007 Aug; 110(3):827-32. PubMed ID: 17416735
[TBL] [Abstract][Full Text] [Related]
12. [Analyses of risk factors for temporarily inhibited parathyroid hormone secretion of postoperative primary hyperparathyroidism].
Liu X; Zhao T; Wang JC; Shen H; Wang Q; Xin YH; Wei BB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):497-500. PubMed ID: 32842365
[No Abstract] [Full Text] [Related]
13. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
[TBL] [Abstract][Full Text] [Related]
14. High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.
Gu Y; Yuan YH; Xu J; Shi QL; Qu XY; Guo R; Bai H; Xu JD; Li JY; Chen LJ
Oncotarget; 2017 Jul; 8(29):48350-48361. PubMed ID: 28418851
[TBL] [Abstract][Full Text] [Related]
15. Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens.
Bai J; Wang J; Yang Y; Zhang W; Wang F; Zhang L; Chen H; Wang X; Feng Y; Shen Y; Huang L; He A
Hematology; 2019 Dec; 24(1):387-391. PubMed ID: 30890040
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum parathyroid hormone level in acute decompensated heart failure.
Sugimoto T; Dohi K; Onishi K; Yamada T; Horiguchi M; Takamura T; Kawamura A; Seko T; Nakamura M; Kasai A; Ito M
Circ J; 2014; 78(11):2704-10. PubMed ID: 25253620
[TBL] [Abstract][Full Text] [Related]
17. Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?
Notarfranchi L; Marchica V; Dalla Palma B; Pelagatti L; Burroughs-Garcia J; Pedrazzoni M; Ruffini L; Cetani F; Marcocci C; Giuliani N
Acta Haematol; 2021; 144(3):302-307. PubMed ID: 32906140
[TBL] [Abstract][Full Text] [Related]
18. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
[TBL] [Abstract][Full Text] [Related]
19. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
[TBL] [Abstract][Full Text] [Related]
20. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]